The European Medicines Agency has introduced a new draft guideline entitled "Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container." The document was issued in April 2016.
As
the introduction to the document states: “Sterility is a critical quality
attribute for all sterile products. Sterility of the medicinal product cannot
be assured by testing; it needs to be assured by the use of a suitable and
validated manufacturing process. Sterility is dependent on several factors such
as the bioburden of the formulation components, the sterilisation procedure,
the integrity of the container closure system, (abbreviated as container in
this document), and in the case of aseptic processing, the use of satisfactory
aseptic technique.”
The
document looks at the following processes:
- Steam sterilisation
- Dry heat sterilisation
- Ionisation radiation sterilisation
- Gas sterilisation
- Sterile filtration
- Aseptic processing
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources